Showing results (1-10 of 792) with videos related to
Sort By:
Pageof 80
Med (New York, N.Y.)|May 19, 2022
Targeting Epstein-Barr virus to treat MSTanuja Chitnis, Howard L WeinerThe Journal of Clinical Investigation|September 6, 2017
CNS inflammation and neurodegenerationTanuja Chitnis, Howard L WeinerAnnals of Clinical and Translational Neurology|November 4, 2020
Blood neurofilament light: a critical review of its application to neurologic diseaseChristian Barro, Tanuja Chitnis, Howard L WeinerMultiple Sclerosis and Related Disorders|July 21, 2021
Review of Phase III Clinical Trials Outcomes in Patients with Secondary Progressive Multiple SclerosisMatthew McAdams, James M Stankiewicz, Howard L Weiner, et al.Frontiers in Neurology|July 12, 2021
Validation of Two Kinetic Assays for the Quantification of Endotoxin in Human SerumChristian Barro, Anu Paul, Fermisk Saleh, et al.Multiple Sclerosis and Related Disorders|October 16, 2025
Assessment of changes in fatigue and cognitive functioning in the absence of progression independent of relapse activityBonnie I Glanz, Tanuja Chitnis, Howard L Weiner, et al.Journal of Psychosomatic Research|September 24, 2020
Social support in multiple sclerosis: Associations with quality of life, depression, and anxietyAdrianna Ratajska, Bonnie I Glanz, Tanuja Chitnis, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 16, 2021
Patient-reported outcomes associated with transition to secondary progressive multiple sclerosisBrian C Healy, Jonathan Zurawski, Tanuja Chitnis, et al.Ebiomedicine|May 9, 2025
Faecal mucoprotein MUC2 is decreased in multiple sclerosis and is associated with mucin degrading bacteriaLuke A Schwerdtfeger, Federico Montini, Tanuja Chitnis, et al.Multiple Sclerosis and Related Disorders|July 11, 2022
Estimating the association between physical activity and health-related quality of life in individuals with multiple sclerosisBrian C Healy, Emily C Casady, Tanuja Chitnis, et al.Pageof 80